We are thrilled to announce the grand opening of the Apeloa Pharma Solutions R&D center in Billerica, MA. This state-of-the-art lab space marks a major milestone in Apeloa Pharmaceutical Co., Ltd's commitment to continuous innovation and providing better service globally.
On September 10th, we celebrated the R&D center's official opening with a ribbon cutting joined by leaders from Apeloa, Town of Billerica government representatives, our local team, and nearly 100 partners and friends from the local pharmaceutical and biotech community.
Tours followed, showcasing our 17,000 square foot facility. These tours highlighted our goal to provide customers with services such as preclinical chemistry route exploration, scale-up for kilogram-scale production, and new modality platform development in the areas of PROTAC, ADC, and peptide synthesis. A Boston-based team of experienced scientists leading these tours has been established to provide support to match the evolving chemistry needs of the drug development field.
With a reception to complete the celebration of this momentous occasion, we emphasized the center's strategic emphasis on driving technological innovation and reflected on the journey of building Apeloa's first US lab site.
We look forward to pushing the boundaries of drug discovery and development together in the hub of scientific innovation! Stay tuned for more updates.
